rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2002-7-3
|
pubmed:abstractText |
A frequent cause of conjunctivitis is an acute bacterial infection, presenting with mucopurulent discharge and conjunctival hyperemia. The authors compared the clinical and microbiologic efficacy, safety and acceptability of 1% fusidic acid viscous drops (Fucithalmic) with 0.3% tobramycin ophthalmic solution (Tobrex) in the treatment of suspected bacterial conjunctivitis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0008-4182
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
228-37; discussion 237
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12095096-Adolescent,
pubmed-meshheading:12095096-Adult,
pubmed-meshheading:12095096-Aged,
pubmed-meshheading:12095096-Aged, 80 and over,
pubmed-meshheading:12095096-Anti-Bacterial Agents,
pubmed-meshheading:12095096-Child,
pubmed-meshheading:12095096-Child, Preschool,
pubmed-meshheading:12095096-Conjunctivitis, Bacterial,
pubmed-meshheading:12095096-Female,
pubmed-meshheading:12095096-Fusidic Acid,
pubmed-meshheading:12095096-Humans,
pubmed-meshheading:12095096-Male,
pubmed-meshheading:12095096-Middle Aged,
pubmed-meshheading:12095096-Ophthalmic Solutions,
pubmed-meshheading:12095096-Patient Compliance,
pubmed-meshheading:12095096-Patient Satisfaction,
pubmed-meshheading:12095096-Single-Blind Method,
pubmed-meshheading:12095096-Tobramycin
|
pubmed:year |
2002
|
pubmed:articleTitle |
Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.
|
pubmed:affiliation |
University of Ottawa Eye Institute, Ottawa Hospital, Ont. bjackson@ohri.ca
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|